NCT00646087View on ClinicalTrials.gov

Ketamine Frequency Treatment for Major Depressive Disorder

PHASE4WithdrawnINTERVENTIONAL

0

Timeline

Start Date

March 31, 2008

Conditions

Treatment Resistant Depression

Interventions

DRUG

Ketamine

0.5 mg/kg of ketamine every other day for 12 days (days 1, 3, 5, 7, 9, 11)

DRUG

Ketamine/Saline

0.5 mg/kg of ketamine on days 1 and 7, placebo (saline) on days 3, 5, 9, 11

Trial Locations (1)

55805

St. Mary's Duluth Clinic Health System, Duluth

Sponsors

Lead Sponsor

Essentia Health

All Listed Sponsors

lead

Essentia Health

OTHER

NCT00646087 - Ketamine Frequency Treatment for Major Depressive Disorder | Biotech Hunter | Biotech Hunter